Journal of Translational Medicine · 2011 · 44 citations · 28 references
MedicineMolecular BiologyOncologyCarcinogenesisEpigeneticsMolecular OncologyCancer EpigeneticsDna Methylation ProfilingEpigenetic Regulation In CancerMalignant NeoplasmsMicrorna BiologyMyeloproliferative NeoplasmsCpg Island Promoter MethylationEpigenetic Silencing Of Tumor Suppressor GenesMethylation-specific AmplificationMicrorna EpigeneticsMicrorna-mediated Epigenetic ControlPhiladelphia Chromosome-negative Myeloproliferative NeoplasmsTumor Suppressor Gene HypermethylationTumor Suppressor Gene Methylation
BACKGROUND: MicroRNA (miR) miR-34a, -34b/c, -124-1 and -203 are tumor suppressor miRs implicated in carcinogenesis. METHODS: We studied DNA methylation of these miRs in Philadelphia-negative (Ph-ve) myeloproliferative neoplasms (MPNs). Methylation-specific PCR (MSP), verified by direct sequencing of the methylated MSP products, was performed in cell lines, normal controls and diagnostic marrow samples of patients with MPNs. RESULTS: Methylation of these miRs was absent in the normal controls. miR-34b/c were homozygously methylated in HEL cells but heterozygously in MEG-01. In HEL cells, homozygous miR-34b/c methylation was associated with miR silencing, and 5-aza-2'-deoxycytidine treatment led to re-expression of both miR-34b and miR-34c, consistent with that both miRs are under the regulation of the same promoter CpG island. miR-34a was heterozygously methylated in MEG-01 and K-562. miR-203 was completely unmethylated in K-562 and SET-2 but no MSP amplification was found in both HEL and MEG-01, suggestive of miR deletion. In primary samples, four each had miR-34b/c and -203 methylation, in which two had concomitant methylation of miR-34b/c and -203. miR-34a was methylated in one patient and none had methylation of miR-124-1. Seven patients (15.6%) had methylation of at least one of the four miRs. miR methylation did not correlate with clinical parameters, disease complications or JAK2 V617F mutation. CONCLUSION: This is the first report of miR hypermethylation in MPNs. miR-203 hypermethylation is not specific to Ph+ve leukemias but also present in Ph-ve MPNs. miR-34b/c methylation was associated with reversible miR silencing. There was no correlation of miR methylation with clinical demographic data or outcome.
28
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Amaia Lujambio, Santiago Ropero, Esteban Ballestar et al. · Cancer Research · 2007 · 936 citations · Full text
Ayalew Tefferi, Jüergen Thiele, Attilio Orazi et al. · Blood · 2007 · 858 citations · Full text
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Dmitri Lodygin, Valery Tarasov, Alexey Epanchintsev et al. · Cell Cycle · 2008 · 784 citations · Full text